Literature DB >> 2975598

Structural and serological heterogeneity of gamma/delta T cell antigen receptor expression in thymus and peripheral blood.

L L Lanier1, J Ruitenberg, R L Bolhuis, J Borst, J H Phillips, R Testi.   

Abstract

Monoclonal antibodies (mAb) reactive against the gamma/delta T cell antigen receptor (TcR) have been used to characterize the distribution and structural properties of gamma/delta TcR-bearing lymphocytes in blood and thymus. Consistent with prior reports the TcR gamma/delta-1 and delta-1 mAb react with all gamma/delta TcR+ T lymphocytes in blood and thymus. By contrast the TCS-delta mAb was found only to react with a subset of the gamma/delta TcR-bearing T cell population. Several lines of evidence suggest that this reagent preferentially reacts with the V delta 1 gene product. Using these reagents, it was observed that gamma/delta TcR+ T lymphocytes comprise 4.6 +/- 3.5% (range 1.0-16.3%) of peripheral blood lymphocytes. However, analysis of peripheral blood from normal adult donors revealed that in 29 of 32 the TCS-delta (possibly V delta 1)-bearing cells comprised less than 30% of the total gamma/delta-TcR+ population. Biochemical analysis demonstrated that the predominant form of the gamma/delta TcR in adult peripheral blood is a disulfide-linked heterodimer, indicating preferential use of the C gamma 1 gene. The delta TcR chain from these TcR-gamma/delta-1+/TCS-delta- T cells was remarkably basic in charge, as analyzed by nonequilibrium pH gradient electrophoresis. By contrast with peripheral blood the majority of freshly isolated and interleukin 2-cultured gamma/delta TcR+ thymocytes were predominantly TcR-gamma/delta-1+/TCS-delta +, and preferentially expressed V delta 1. Moreover, both disulfide-bonded and nondisulfide-bonded gamma/delta TcR heterodimers were expressed in all thymuses examined and both forms were contained within the TCS-delta + thymic subset. Similar to recent findings in the mouse, these studies suggest a possible bias in the structural form of gamma/delta TcR based on tissue location.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2975598     DOI: 10.1002/eji.1830181218

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

Review 1.  Human gamma delta T lymphocytes in HIV disease: effector functions and control by natural killer cell receptors.

Authors:  M L Gougeon; F Poccia; S Boullier
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Concurrent and independent binding of Fcgamma receptors IIa and IIIb to surface-bound IgG.

Authors:  T E Williams; S Nagarajan; P Selvaraj; C Zhu
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

3.  Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections.

Authors:  M Wallace; A M Scharko; C D Pauza; P Fisch; K Imaoka; S Kawabata; K Fujihashi; H Kiyono; Y Tanaka; B R Bloom; M Malkovsky
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

Review 4.  Structure and function of the T cell antigen receptor.

Authors:  A Weiss
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

5.  Gamma delta T-cell receptor repertoire in human peripheral blood and thymus.

Authors:  H Vietor; F Koning
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma.

Authors:  Joshua M Lang; Mahazarin R Kaikobad; Marianne Wallace; Mary Jane Staab; Dorothea L Horvath; George Wilding; Glenn Liu; Jens C Eickhoff; Douglas G McNeel; Miroslav Malkovsky
Journal:  Cancer Immunol Immunother       Date:  2011-06-07       Impact factor: 6.968

7.  A randomized phase II trial evaluating different schedules of zoledronic acid on bone mineral density in patients with prostate cancer beginning androgen deprivation therapy.

Authors:  Joshua M Lang; Marianne Wallace; Jordan T Becker; Jens C Eickhoff; Bjoern Buehring; Neil Binkley; Mary Jane Staab; George Wilding; Glenn Liu; Miroslav Malkovsky; Douglas G McNeel
Journal:  Clin Genitourin Cancer       Date:  2013-07-05       Impact factor: 2.872

8.  Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria.

Authors:  L Hviid; J A Kurtzhals; V Adabayeri; S Loizon; K Kemp; B Q Goka; A Lim; O Mercereau-Puijalon; B D Akanmori; C Behr
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

9.  Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis.

Authors:  R Shimonkevitz; C Colburn; J A Burnham; R S Murray; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

10.  T-cell receptor heterogeneity of gamma delta T-cell clones from human female reproductive tissues.

Authors:  S E Christmas; R Brew; G Deniz; J J Taylor
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.